Navigation Links
ACTwatch, to Improve Malaria Treatment, to Be Launched on World Malaria Day
Date:4/24/2008

NAIROBI, Kenya, April 24 /PRNewswire-USNewswire/ -- A multi-country project called ACTwatch, which will monitor the availability and affordability of effective malaria treatment, will be launched in Nairobi Friday -- World Malaria Day. Over the next five years, ACTwatch, which is funded by a grant from the Bill & Melinda Gates Foundation, will provide ongoing evidence related to access to antimalarials, specifically artemisinin-based combination therapies (ACTs), the most effective malaria treatment on the market. This evidence will inform policy discussions ongoing at both the global and country level to increase access to effective antimalarials for those who need them most.

ACTwatch is being implemented by a consortium of partners led by the nongovernmental organization PSI. Other partners include the London School of Hygiene and Tropical Medicine, United States Pharmacopeia and the market research firm, Nielsen. The project will be carried out in six African countries (Benin, Democratic Republic of Congo, Madagascar, Nigeria, Uganda and Zambia) and two countries in Southeast Asia (Cambodia and one other, yet to be decided upon).

Studies conducted under the auspices of the project will examine the price, availability and quality of different types of antimalarials in shops and health facilities. Studies will also investigate malaria treatment seeking behavior in the community and the functioning of the supply chain for antimalarials as well as look at the effect of government policies on the structure of the antimalarial market in each country. The principal outputs of ACTwatch will be evidence on changes in the availability, affordability and use of ACTs, in all sectors, as well as policy recommendations targeting national and international decision-makers to increase use of ACTs in vulnerable communities.

Over the past two to three years, ACTs have become the malaria treatment of choice and have replaced drugs, such as chloroquine, which have become ineffective due to the emergence of resistant malaria parasites. While ACTs are extremely effective in treating malaria, they are sold for up to 10 times the price of chloroquine. As a result, major donor initiatives, such as the Global Fund to Fight AIDS, Tuberculosis and Malaria, have provided funds to individual countries to procure ACTs for supply through public health facilities to treat patients sick with malaria.

While public facilities in most malaria endemic countries provide ACTs at low cost or for free, almost half of all malaria patients access treatment through shops, where many kinds of antimalarials, of varying quality, can be found. Few shops stock ACTs because they are so expensive and most patients continue to buy ineffective malaria treatments because that is all that they can afford. To address this problem, both global and national financing initiatives to subsidize the price of ACTs are underway. ACTwatch will provide ongoing feedback to these programs, and measure the extent to which these initiatives have been successful.

For more information on ACTwatch, visit http://www.actwatch.info

The mission of PSI is to measurably improve the health of poor and vulnerable people in the developing world, principally through social marketing of family planning and health products and services, and behavior change communications. Social marketing engages private sector resources and uses private sector techniques to encourage healthy behavior and make markets work for the poor.


'/>"/>
SOURCE Population Services International
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Vision restoration therapy shown to improve brain activity in brain injured patients
2. Broad-based group of physicians calls for improvement in stroke treatment
3. Frequent Prostate Screens Fail to Improve Aggressive Cancer Diagnoses
4. Pill box organizers increase HIV patients adherence and improve viral suppression
5. Treating depression may improve recovery of heart rate variability following coronary syndromes
6. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
7. AWWA, National Association of Water and Sanitation of Mexico, Agree to Share Expertise and Resources for Improved Water Supply
8. Exercise and yoga improves quality of life in women with early-stage breast cancer
9. QI projects may -- or may not -- improve patient safety and outcomes
10. National Association for Sport and Physical Education Partners with S&S Worldwide to Help Improve Childrens Fitness
11. MedQuist Re-launches New, Improved Web Site
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... Judy Buchanan, co-owner ... in Frederick, MD. Judy says, “I am passionate about sharing Reiki as a ... very difficult and challenging time.” , A Certified Medical Reiki™ Master trained by ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Vintage and Harvest A Cultivation ... and college Bible teacher residing in North Carolina with his wife, Anna Marie. He ... them with six grandchildren. David is also the author of “Shadow and Substance.” , ...
(Date:3/23/2017)... ... 2017 , ... In 2016 the World Health Organization declared the Zika virus ... Zika-related cases in the Americas within the next year. Lyme disease is one of ... skyrocketing to an estimated 329,000. Yet, Zika, Lyme and other insect borne illnesses are ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... their communities, 16 more public health departments have been awarded national accreditation through ... 4.5 million people into the expanding network of communities across the nation whose ...
(Date:3/23/2017)... , ... March 23, 2017 , ... The IoT (Internet ... WiFi connectivity are making a huge impact on businesses and individual consumers alike. ... the IoT will have a value anywhere from $4 trillion to $11 trillion dollars ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... 23, 2017  Mirabilis Medical, a ... for non-invasive surgery, announced today CE Mark authorization ... of uterine fibroids throughout the European Union.  The ... from the US Food and Drug Administration to ... in the United States.  The Mirabilis System combines ...
(Date:3/24/2017)... GENEVA , March 24, 2017 ... revitalizes efforts to develop sutezolid as effective response to ... Day, TB Alliance and the Medicines Patent Pool (MPP) ... sutezolid, an antibiotic drug candidate which demonstrated encouraging results ... of sutezolid in combination with other TB drugs and ...
(Date:3/23/2017)... DUBLIN , Mar 23, 2017 Research ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... CAGR of around 6.9% over the next decade to reach approximately ... market estimates and forecasts for all the given segments on global ...
Breaking Medicine Technology: